KALA BIO, Inc.
KALA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479419
No open-market purchases or sales by KALA BIO, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.21M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding KALA BIO, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 29 | 30 | +1 |
| Shares | 4.14M | 3.64M | −500.0K (−12.1%) |
| Value | $23.7M | $17.3M | −$6.40M (−27.0%) |
New holders (5)
Institutions that held KALA BIO, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 17,400 | $82.8K | 0.00% |
| XTX Topco Ltd | 12,990 | $61.8K | 0.00% |
| Advisor Group Holdings, Inc. | 100 | $476 | 0.00% |
| Legacy Investment Solutions, LLC | 25 | $119 | 0.00% |
| Raymond James Financial Inc | 7 | $33 | 0.00% |
Sold out (4)
Institutions that held KALA BIO, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Silverarc Capital Management, LLC | 246,079 | $1.41M |
| Readystate Asset Management LP | 42,459 | $243.3K |
| Curio Wealth, LLC | 1 | $139 |
| Binnacle Investments Inc | 8 | $46 |